Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

ProstaLund

Less than 1K followers
Overview
Investor views
All
Press releases
3rd party
ShowingAll content types

Regulatory press release24.10.2025 klo 08.30

PROSTALUND AB (publ) - Interim report January-September 2025

ProstaLund
Press release12.09.2025 klo 09.00

ProstaLund enters collaboration agreement with the XEN Group for the market in the United Arab Emirates and Oman

ProstaLund
Press release10.09.2025 klo 09.00

ProstaLund enters collaboration agreement with Mayumana Healthcare for the Benelux market

ProstaLund

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release21.08.2025 klo 08.30

ProstaLund AB - Interim Report January-June 2025

ProstaLund
Press release26.06.2025 klo 17.45

First CoreTherm® Eagle treatments performed in Denmark

ProstaLund
Press release17.06.2025 klo 11.00

Second clinic in Sweden starts treatment with CoreTherm® Eagle

ProstaLund
Regulatory press release30.05.2025 klo 08.30

ProstaLund AB - Interim report January-March 2025

ProstaLund
Press release20.05.2025 klo 16.50

First patients treated with CoreTherm® Eagle

ProstaLund
Press release14.05.2025 klo 11.45

First treatments with CoreTherm® Eagle to be performed next week – Key milestone for ProstaLund

ProstaLund
Press release24.02.2025 klo 16.00

Correction: Use of the Schelin Catheter® prior to water vapor thermal therapy shown to be cost-effective

ProstaLund
Press release24.02.2025 klo 10.05

Use of the Schelin Catheter® prior to water vapor thermal therapy shown to be cost-effective

ProstaLund
Regulatory press release20.02.2025 klo 08.30

ProstaLund AB - Year-end report 2024

ProstaLund
Press release14.02.2025 klo 16.45

New study confirms the strong efficacy of CoreTherm® in patients with large prostates

ProstaLund
Press release27.01.2025 klo 11.00

Elderly men treated with CoreTherm® for benign prostatic hyperplasia have lower risk for a prostate cancer diagnosis later in life compared to men treated with TURP, according to a new Swedish register study

ProstaLund
Press release10.12.2024 klo 10.00

Additional study published confirming effectiveness of transurethral intraprostatic anaesthesia (TUIA) using our Schelin Catheter® during benign prostatic enlargement treatments

ProstaLund
Third party research11.11.2024 klo 14.11

ProstaLund: CoreTherm Eagle flygfärdig - VH Corp

* Tio CoreTherm Eagle-maskiner är tillverkade * Förbättrat patientflöde jämfört med första halvåret * Vi behåller vårt motiverade värde om 0,81 SEK per aktie ProstaLunds nettoomsättning i Q3 om 3,5 MSEK var klart lägre jämfört med samma period 2023. ...

ProstaLund
Press release07.11.2024 klo 13.00

The first ten CoreTherm® Eagle machines are manufactured

ProstaLund
Regulatory press release07.11.2024 klo 08.30

Interim report January-September 2024

ProstaLund
Press release11.10.2024 klo 11.00

Short-term results and long-term durability after CoreTherm® treatments presented at the Emirates International Urological Conference in Dubai, UAE

ProstaLund
Press release04.10.2024 klo 14.00

First published report of transurethral intraprostatic anaesthesia (TUIA) using the Schelin Catheter® in patients undergoing holmium laser enucleation of the prostate

ProstaLund